About Tenpoint Therapeutics
Tenpoint Therapeutics develops treatments for presbyopia, cataracts, and geographic atrophy. The company partners with eye care professionals to address the needs of aging eyes. Tenpoint Therapeutics announced FDA acceptance of a New Drug Application for BRIMOCHOL™ PF for the treatment of presbyopia.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Camborne, United Kingdom
Team Size
101-250
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
tenpointtherapeutics.com
Domain Registered Date
Dec 3, 2020
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-A announced
fundraisingfox.com
- Capital Raise
Raised $235,000,000 · Series-B+
fundraisingfox.com
- Milestone
Website domain registered
tenpointtherapeutics.com
- Milestone
X account created (@Tenpoint_Tx)
639 followers
Investors & Backers
AdBio partners
British Business Bank
Eight Roads Ventures
EQT
EQT Life Sciences
F-Prime Capital
Hercules Capital
Hillhouse Investment
Janus Henderson Investors
Qiming Venture Partners USA
Sofinnova Partners
Wille Finance
Funding History
Series-A
· Jun 12, 2026
Undisclosed fundraisingfox.com
Series-B+
· Jan 29, 2026
$235,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026